Condition: Infant Development · Cerebral Palsy · Motor Disorders · Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical complexity. The study team plans to recruit 100 healthy, term-born infants and 250 infants at risk of developing CP for a total of 350 enrolled infants.
This description comes directly from the study's public registry record.
Imani Mann, B.S. · 630-248-3514 · imani.mann@northwestern.edu
Colleen Peyton, DPT · colleen.peyton1@northwestern.edu
Always discuss trial participation with your own doctor first.
| Feinberg School of Physical Therapy and Human Movement Sciences | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06278961